{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:24:16Z","timestamp":1781763856829,"version":"3.54.5"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","canadianjournalofophthalmology.ca","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jcjo.2023.12.004","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T12:49:40Z","timestamp":1705495780000},"page":"e293-e296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sustained remission of pediatric choroidal neovascular membrane secondary to choroidal rupture with intravitreal aflibercept"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7069-3162","authenticated-orcid":false,"given":"Brendan Ka-Lok","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Koushan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2023.12.004_bib0001","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.survophthal.2021.01.014","article-title":"The choroidal rupture: current concepts and insights","volume":"66","author":"Lupidi","year":"2021","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.12.004_bib0002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12886-019-1242-7","article-title":"Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture","volume":"19","author":"Barth","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.12.004_bib0003","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00417-009-1098-2","article-title":"Intravitreal ranibizumab for choroidal neovascularization related to traumatic Bruch's membrane rupture","volume":"247","author":"Liang","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2023.12.004_bib0004","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/PHMT.S391591","article-title":"Role of anti\u2013vascular endothelial growth factor (anti-VEGF) in the treatment of retinopathy of prematurity: a narrative review in the context of middle-income countries","volume":"14","author":"Dogra","year":"2023","journal-title":"Pediatr Health Med Ther"},{"key":"10.1016\/j.jcjo.2023.12.004_bib0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Ghasemi Falavarjani","year":"2013","journal-title":"Eye (Lond)"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418223003848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418223003848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T20:20:43Z","timestamp":1728937243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418223003848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0008418223003848"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2023.12.004","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained remission of pediatric choroidal neovascular membrane secondary to choroidal rupture with intravitreal aflibercept","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}